Balamenib

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameBalamenib
Drug Alias NameBalomenibZE63-0302ZE-630302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin inhibitors
TargetsMenin
Therapy Area/IndicationsDiabetes Mellitus, Type 2Leukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUzbekistanNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Leukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A